2025-02-08
From February 3rd to 6th, the largest medical exhibition in the Middle East, Medlab 2025, was successfully held at the Dubai World Trade Centre. Nearly a thousand medical enterprises and tens of thousands of industry experts and professionals from over a hundred countries participated in the event. KHB, together with its subsidiaries Tianlong Technology, Guangzhou Focus Diagnostics, and Italy's Technogenetics S.P.A. (TGS), made a grand appearance. The spotlight was on multiple cutting-edge innovations, attracting numerous experts and partners for in-depth discussions.
KHB Polaris V150: Advancing CLIA to a New Level
At this exhibition, the Polaris V150 Chemiluminescence Immunoassay System stood out as a popular highlight. Users from Egypt, Syria, India, and other regions had made early reservations for hands-on experiences, leading to enthusiastic discussions on-site. The device is compatible with a variety of reagents, meeting diverse testing needs and has already been successfully deployed in hospitals and laboratories across multiple countries and regions.
KHB ZY-260: Compact Yet Powerful for Versatile Applications
Another star product was the ZY-260 Biochemistry Analyzer, which amazed attendees with its compact design and powerful biochemical testing capabilities. In just one year since its international launch, the KHB ZY-260 has gained widespread recognition and trust for its accurate testing performance, stable operation, and outstanding compatibility. Several international partners have expressed plans to expand their procurement in 2025 and introduce more KHB devices into their local markets. KHB will continue working closely with regional partners to enhance technical support and service guarantees, ensuring excellent product quality while expanding its global market presence.
KHB Diagnostic Reagents: Globally Certified and Expanding Internationally
KHB’s portfolio of over 400 IVD reagents, covering biochemistry, immunology, molecular diagnostics, POCT and mass spectrometry platforms, also attracted significant attention. Notably, its HIV (1+2) rapid diagnostic kit has not only obtained CE IVDR certification but has also been awarded the WHO PQ certification, signifying its outstanding global quality and reliability. In recent years, KHB’s ELISA test kits have been recognized for their high sensitivity and specificity, achieving multiple international certifications and standing out in various government bidding projects.
Group Products: Innovation in the Spotlight
Several innovative products from KHB’s subsidiaries also captivated attendees at the event, including the Tianlong Panall 8000 All-In-One Molecular Diagnosis System, capable of screening 24 pathogens in a single test from sample to result. Additionally, the Biolum ATP Hygiene Monitoring System, which won the Red Dot Award and delivers results in just 10 seconds, also gained significant interest. The innovative designs, user-friendly operation, and precise detection capabilities drew widespread attention and admiration.
Deep Collaboration for Mutual Success
KHB’s presence at Medlab 2025 was not just about showcasing products—it also facilitated meaningful interactions with new and existing customers. Through in-depth discussions with our professional team, attendees gained deeper insights into the technical specifications, clinical applications, and after-sales services of KHB’s flagship products. As a result, numerous cooperation agreements were reached with partners from Russia, India, the UAE, and beyond. Notably, a client from Egypt signed an exclusive distribution agreement for the Biolum ATP series in the local market.
With cutting-edge innovations and strengthened global partnerships, KHB has successfully concluded its participation in Medlab 2025 in Dubai. Looking ahead, the company remains committed to its mission of “Care for life, Dedicate to excellence” and will continue to introduce more high-quality products and solutions to advance global healthcare development.
2025—More Surprises Await, Stay Tuned!